Literature DB >> 20154219

CLEC-2 activates Syk through dimerization.

Craig E Hughes1, Alice Y Pollitt, Jun Mori, Johannes A Eble, Michael G Tomlinson, John H Hartwig, Christopher A O'Callaghan, Klaus Fütterer, Steve P Watson.   

Abstract

The C-type lectin receptor CLEC-2 activates platelets through Src and Syk tyrosine kinases, leading to tyrosine phosphorylation of downstream adapter proteins and effector enzymes, including phospholipase-C gamma2. Signaling is initiated through phosphorylation of a single conserved tyrosine located in a YxxL sequence in the CLEC-2 cytosolic tail. The signaling pathway used by CLEC-2 shares many similarities with that used by receptors that have 1 or more copies of an immunoreceptor tyrosine-based activation motif, defined by the sequence Yxx(L/I)x(6-12)Yxx(L/I), in their cytosolic tails or associated receptor chains. Phosphorylation of the conserved immunoreceptor tyrosine-based activation motif tyrosines promotes Syk binding and activation through binding of the Syk tandem SH2 domains. In this report, we present evidence using peptide pull-down studies, surface plasmon resonance, quantitative Western blotting, tryptophan fluorescence measurements, and competition experiments that Syk activation by CLEC-2 is mediated by the cross-linking through the tandem SH2 domains with a stoichiometry of 2:1. In support of this model, cross-linking and electron microscopy demonstrate that CLEC-2 is present as a dimer in resting platelets and converted to larger complexes on activation. This is a unique mode of activation of Syk by a single YxxL-containing receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154219      PMCID: PMC4361903          DOI: 10.1182/blood-2009-08-237834

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.

Authors:  D W Wolan; L Teyton; M G Rudolph; B Villmow; S Bauer; D H Busch; I A Wilson
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

2.  Requirement for a negative charge at threonine 60 of the FcRgamma for complete activation of Syk.

Authors:  P G Swann; S Odom; Y J Zhou; Z Szallasi; P M Blumberg; P Draber; J Rivera
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

3.  Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.

Authors:  A S Kim; L T Kakalis; N Abdul-Manan; G A Liu; M K Rosen
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

4.  alpha 2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen.

Authors:  J A Eble; B Beermann; H J Hinz; A Schmidt-Hederich
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

5.  Renal cells activate the platelet receptor CLEC-2 through podoplanin.

Authors:  Charita M Christou; Andrew C Pearce; Aleksandra A Watson; Anita R Mistry; Alice Y Pollitt; Angharad E Fenton-May; Louise A Johnson; David G Jackson; Steve P Watson; Chris A O'Callaghan
Journal:  Biochem J       Date:  2008-04-01       Impact factor: 3.857

6.  The clearance mechanism of chilled blood platelets.

Authors:  Karin M Hoffmeister; Thomas W Felbinger; Hervé Falet; Cécile V Denis; Wolfgang Bergmeier; Tanya N Mayadas; Ulrich H von Andrian; Denisa D Wagner; Thomas P Stossel; John H Hartwig
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

7.  Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.

Authors:  Elizabeth E Gardiner; Denuja Karunakaran; Jane F Arthur; Fi-Tjen Mu; Maree S Powell; Ross I Baker; P Mark Hogarth; Mark L Kahn; Robert K Andrews; Michael C Berndt
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113

8.  Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.

Authors:  Aleksandra A Watson; Johannes A Eble; Chris A O'Callaghan
Journal:  Protein Sci       Date:  2008-06-26       Impact factor: 6.725

9.  CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils.

Authors:  Ann M Kerrigan; Kevin M Dennehy; Diego Mourão-Sá; Inês Faro-Trindade; Janet A Willment; Philip R Taylor; Johannes A Eble; Caetano Reis e Sousa; Gordon D Brown
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

10.  CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes.

Authors:  Cristal Huysamen; Janet A Willment; Kevin M Dennehy; Gordon D Brown
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

View more
  60 in total

1.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

2.  The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).

Authors:  Björn Bauer; Tanja Wotapek; Tobias Zöller; Emilia Rutkowski; Alexander Steinle
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

3.  Identification of a chicken CLEC-2 homologue, an activating C-type lectin expressed by thrombocytes.

Authors:  Marie-Luise Neulen; Thomas W Göbel
Journal:  Immunogenetics       Date:  2011-12-29       Impact factor: 2.846

4.  Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

Authors:  Shideh Kazerounian; Mark Duquette; Millys A Reyes; James T Lawler; Keli Song; Carole Perruzzi; Luca Primo; Roya Khosravi-Far; Federico Bussolino; Isaac Rabinovitz; Jack Lawler
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

5.  Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling.

Authors:  Aleksandra A Watson; Andrey A Lebedev; Benjamin A Hall; Angharad E Fenton-May; Alexei A Vagin; Wanwisa Dejnirattisai; James Felce; Juthathip Mongkolsapaya; Angelina S Palma; Yan Liu; Ten Feizi; Gavin R Screaton; Garib N Murshudov; Christopher A O'Callaghan
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

7.  Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI.

Authors:  Phillip L R Nicolson; Craig E Hughes; Stephanie Watson; Sophie H Nock; Alexander T Hardy; Callum N Watson; Samantha J Montague; Hayley Clifford; Aarnoud P Huissoon; Jean-Daniel Malcor; Mark R Thomas; Alice Y Pollitt; Michael G Tomlinson; Guy Pratt; Steve P Watson
Journal:  Haematologica       Date:  2018-07-19       Impact factor: 9.941

8.  Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.

Authors:  Katsue Suzuki-Inoue; Osamu Inoue; Guo Ding; Satoshi Nishimura; Kazuya Hokamura; Koji Eto; Hirokazu Kashiwagi; Yoshiaki Tomiyama; Yutaka Yatomi; Kazuo Umemura; Yonchol Shin; Masanori Hirashima; Yukio Ozaki
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

9.  A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function.

Authors:  Hervé Falet; Alice Y Pollitt; Antonija Jurak Begonja; Sarah E Weber; Daniel Duerschmied; Denisa D Wagner; Steve P Watson; John H Hartwig
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

Review 10.  Functional significance of the platelet immune receptors GPVI and CLEC-2.

Authors:  Julie Rayes; Steve P Watson; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.